Our study is presumably the first to report an association of the upregulation of LPCAT2 with metabolic alterations in TB patients vs. non-TB controls, suggesting that LPCAT2 can serve as a biomarker in the diagnosis of TB. Here, LPCAT2 is linked to tuberculosis.